Future Health Today Project Echo® Education Sessions – SGLT2 inhibitors
The Future Health Today Project ECHO® series for SGLT2 inhibitors for the management of type 2 diabetes is available now for registration.
7-8pm, Thursdays via Zoom
Series facilitated by Lauren Cussen, Academic GP
28 July 2022: SGLT2i for hyperglycaemia management in patients with type 2 diabetes
Expert: Shane Hamblin, Endocrinologist
11 August 2022: SGLT2i for type 2 diabetes management in patients at risk of, or diagnosed with, CVD
Expert: Ralph Audehm, Academic GP
25 August 2022: SGLT2i for type 2 diabetes management in patients diagnosed with CKD
Expert: Adam Flavell, Nephrologist
Participants will learn the latest evidence and complexities around the use of SGLT2 inhibitors for the management of type 2 diabetes. The hub and spoke model of Project ECHO® brings best practice care to the front line and enables faster intervention at the community level. It provides an opportunity for participants to share de-identified cases from their practice and receive advice and support from the general practice community and topic experts.
This series is intended for GPs, nurses, registrars and practice managers.